Lessons Learned: Implementation of the Young Key Populations Programmes in the Global Fund GrantSeptember 2019 read more
Publisher: Youth LEAD
LOLIPOP is a programme designed to increase testing, treatment, and adherence, and decrease new infection among young key populations in Indonesia. In 2016, this programme was implemented under the Global Fund Grant. The study aimed to  document activities targeting YKP under Global Fund Grant;  analyse the key achievement and challenge during the programme; and  know how the engagement of YKPs during the planning, implementation, and monitoring of the activities. This study used a qualitative approach through in-depth interviews, while the tools for data collection utilised an input-process-output framework. In total, 16 informants, made up of 7 young beneficiaries, 3 local programme implementers, and 6 national programme implementers from three study sites (Denpasar, Surabaya, West Jakarta) have participated in the primary data collection. The data was analysed thematically to achieve the findings.
Sustainable Health Financing Advocacy
Civil Society Advocacy for Sustainable Financing for Health Sustainable Health Financing Advocacy
Concept Note: As a broad framework, Sustainable health financing advocacy (SHFa) encompasses advocacy across multiple health priorities and in multiple health financing contexts. This unified framework for action can help advocates align eﬀorts, understand the interlinkages and potential synergies for collaboration, and avoid silos in our work.
Download the Full Report here.
Download the Executive Summary here.
Global AIDS update 2019 — Communities at the centre
When communities organize and people empower each other, oppression can be replaced by rights and access to HIV services can be accelerated. Peer-to-peer counsellors, community health workers, door-to-door service providers, grass-roots activists and networks of people living with or affected by HIV all have key roles to play in the response to HIV. As this report shows, community leadership in the AIDS response helps to ensure that HIV services are relevant to, and reach, the people who need them the most.
Getting local: focusing on communities to achieve greater impact in the next phase of the HIV response
Publisher: Journal of the International AIDS Society
Despite numerous achievements in addressing HIV epidemics worldwide, there is still much more that needs to be done to control HIV as a public health threat. As such, the world is at a critical juncture in the HIV response. Decelerating the response now would reverse the enormous gains achieved so far. Achieving a greater impact in the next phase of the HIV response requires an improvement in the quality and integration of services to make the services align to the identified needs of communities.
Are monitoring and evaluation systems adequate to report the programmatic coverage of HIV services among key populations in countries?
Publisher: Infectious Diseases of Poverty
There was no global guidance or agreement regarding when a country has an adequate system to report on the service packages among human immunodeficiency virus (HIV) key populations. This article describes an approach to categorizing the system in a country for reporting the service package among HIV key populations. The approach consists of four dimensions, namely the epidemiological significance, comprehensiveness of the service packages, geographic coverage of services, and adequacy of the monitoring system. The proposed categorization approach utilizes available information and can inform the improvement of the service delivery and monitoring systems among HIV key populations.
Delivering Quality-assured Medical Products for All 2019–2023
Publisher: World Health Organization
Universal health coverage will bring about greater access to medical products, but we must ensure that those products are quality-assured, safe and effective so that they do what they are supposed to do – prevent illness and improve people’s health. That is why today’s launch of WHO’s five-year plan ‘Delivering Quality-assured Medical Products for All 2019–2023’ is important.
Tackling the Triple Transition in Global Health ProcurementJune 2019 read more
Publisher: Center for Global Development
Within a changing global health landscape, a forward-looking approach is needed to anticipate tomorrow’s challenges and plan for the future. To this end, the Center for Global Development convened the Working Group on the Future of Global Health Procurement to review the evidence and formulate recommendations for how the global health community—international health organizations, their bilateral and foundation donors, and low- and middle-income countries—can ensure the medium- to long-term relevance, efficiency, quality, affordability, and security of global health procurement. Importantly, the group limited its focus to the procurement process: the journey of a health product from manufacturer to a centralized warehouse or other wholesaling facility. The downstream supply chain and delivery process—a product’s journey from warehouse to end user—was beyond the Working Group’s scope.
The Challenges of Transition From Donor-Funded Programs…June 2019 read more
Publisher: Global Health: Science and Practice
In the era of declining development assistance for health, transitioning externally funded programs to governments becomes a priority for donors. However, the process requires a careful approach not only to preserve the public health gains that have already been achieved but also to expand on them. In the Eastern Europe and Central Asia region, countries are expected to graduate from support from the Global Fund to Fight AIDS, Tuberculosis and Malaria in or before 2025. We aim to describe transition risks and identify possible means to address them.
The economics of malaria control in an age of declining aidMay 2019 read more
Addressing the structural drivers of HIV: A STRIVE synthesisMay 2019 read more
The past two decades have seen significant progress in tackling HIV. Behavioural interventions have curbed rates of transmission. The scale up of HIV treatment has not only reduced levels of morbidity and mortality, but also created new opportunities for HIV prevention. However, mathematical modelling suggests that, with the current rate of antiretroviral therapy (ART) initiation, 49 million more new HIV infections will occur by 2035, and that even at best, with 90 to 95% coverage, treatment will avert only 60% of new infections.